LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
about
Genomic landscape of human papillomavirus-associated cancersDeciphering Signaling Pathway Networks to Understand the Molecular Mechanisms of Metformin ActionThe Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-AnalysisNKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation.LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitmentDecreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma.Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cellsRepositioning metformin in cancer: genetics, drug targets, and new ways of delivery.HPV16 E6/E7 upregulates HIF-2α and VEGF by inhibiting LKB1 in lung cancer cells.Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation.NKX2-1 expression as a prognostic marker in early-stage non-small-cell lung cancer.Identifying a Novel Biomarker of Clear Cell Renal Cell Carcinoma (ccRCC) Associated with Smoking by Co-Expression Network Analysis
P2860
Q26997399-AFBFCEA1-4C69-4C23-B303-9AB736DD2C6AQ28548411-CB483BFC-CEC0-4782-BC03-1D525FE98B6BQ35976774-CC2E1677-8A07-4E79-B45E-B50FCE710EFEQ35987328-2ED0496C-3361-4170-8B60-5F0B1C39AF81Q36266500-3936EA1A-5C44-4D29-82CA-8599E487A972Q36293714-283D0D0B-EC68-4B5B-9C6D-ADFA3130C062Q36461930-E58B3ECE-059D-4B9F-BA45-F18DC10E9757Q38185970-5C6B263D-9710-4CB3-AC2A-726AFFF0AE14Q38696908-100FB266-AB18-4E75-B0DF-5B15C0C735FEQ40091492-E59E9334-E44F-4699-A62F-8F200C150580Q45874458-1A9E3706-C54A-40CC-84A8-9924B611E34FQ49622015-8A27509E-7FEB-4998-9DC6-78E088675B26Q58576755-6A714512-09CE-4481-9D35-4ACE8C9E1861
P2860
LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
LKB1 loss by alteration of the ...... lapse in lung adenocarcinomas.
@en
LKB1 loss by alteration of the ...... lapse in lung adenocarcinomas.
@nl
type
label
LKB1 loss by alteration of the ...... lapse in lung adenocarcinomas.
@en
LKB1 loss by alteration of the ...... lapse in lung adenocarcinomas.
@nl
prefLabel
LKB1 loss by alteration of the ...... lapse in lung adenocarcinomas.
@en
LKB1 loss by alteration of the ...... lapse in lung adenocarcinomas.
@nl
P2093
P2860
P356
P1433
P1476
LKB1 loss by alteration of the ...... lapse in lung adenocarcinomas.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.353
P407
P577
2013-09-02T00:00:00Z